Financial, market and economic news

Tarsus Pharma Prices IPO Of 5.5 Mln Common Shares At $16/Shr

Tarsus Pharmaceuticals, Inc. announced the pricing of initial public offering of 5.5 million common shares at $16.00 per share, the mid of the expected range of between $15.00 and $17.00 per share.

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy